231 related articles for article (PubMed ID: 21809123)
41. Role for DNA damage signaling in pulmonary arterial hypertension.
Meloche J; Pflieger A; Vaillancourt M; Paulin R; Potus F; Zervopoulos S; Graydon C; Courboulin A; Breuils-Bonnet S; Tremblay E; Couture C; Michelakis ED; Provencher S; Bonnet S
Circulation; 2014 Feb; 129(7):786-97. PubMed ID: 24270264
[TBL] [Abstract][Full Text] [Related]
42. MicroRNA‑15a‑5p induces pulmonary artery smooth muscle cell apoptosis in a pulmonary arterial hypertension model via the VEGF/p38/MMP‑2 signaling pathway.
Zhang W; Li Y; Xi X; Zhu G; Wang S; Liu Y; Song M
Int J Mol Med; 2020 Feb; 45(2):461-474. PubMed ID: 31894295
[TBL] [Abstract][Full Text] [Related]
43. Reoxygenation Reverses Hypoxic Pulmonary Arterial Remodeling by Inducing Smooth Muscle Cell Apoptosis via Reactive Oxygen Species-Mediated Mitochondrial Dysfunction.
Chen J; Wang YX; Dong MQ; Zhang B; Luo Y; Niu W; Li ZC
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28645933
[TBL] [Abstract][Full Text] [Related]
44. PIM1 (Moloney Murine Leukemia Provirus Integration Site) Inhibition Decreases the Nonhomologous End-Joining DNA Damage Repair Signaling Pathway in Pulmonary Hypertension.
Lampron MC; Vitry G; Nadeau V; Grobs Y; Paradis R; Samson N; Tremblay È; Boucherat O; Meloche J; Bonnet S; Provencher S; Potus F; Paulin R
Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):783-801. PubMed ID: 31969012
[TBL] [Abstract][Full Text] [Related]
45. Identification of Celastramycin as a Novel Therapeutic Agent for Pulmonary Arterial Hypertension.
Kurosawa R; Satoh K; Kikuchi N; Kikuchi H; Saigusa D; Al-Mamun ME; Siddique MAH; Omura J; Satoh T; Sunamura S; Nogi M; Numano K; Miyata S; Uruno A; Kano K; Matsumoto Y; Doi T; Aoki J; Oshima Y; Yamamoto M; Shimokawa H
Circ Res; 2019 Jul; 125(3):309-327. PubMed ID: 31195886
[TBL] [Abstract][Full Text] [Related]
46. STIM2 (Stromal Interaction Molecule 2)-Mediated Increase in Resting Cytosolic Free Ca
Song S; Carr SG; McDermott KM; Rodriguez M; Babicheva A; Balistrieri A; Ayon RJ; Wang J; Makino A; Yuan JX
Hypertension; 2018 Mar; 71(3):518-529. PubMed ID: 29358461
[TBL] [Abstract][Full Text] [Related]
47. CPT1 regulates the proliferation of pulmonary artery smooth muscle cells through the AMPK-p53-p21 pathway in pulmonary arterial hypertension.
Zhuang W; Lian G; Huang B; Du A; Gong J; Xiao G; Xu C; Wang H; Xie L
Mol Cell Biochem; 2019 May; 455(1-2):169-183. PubMed ID: 30511343
[TBL] [Abstract][Full Text] [Related]
48. LRP1 promotes synthetic phenotype of pulmonary artery smooth muscle cells in pulmonary hypertension.
Zucker MM; Wujak L; Gungl A; Didiasova M; Kosanovic D; Petrovic A; Klepetko W; Schermuly RT; Kwapiszewska G; Schaefer L; Wygrecka M
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1604-1616. PubMed ID: 30910704
[TBL] [Abstract][Full Text] [Related]
49. Notch3 signaling activation in smooth muscle cells promotes extrauterine growth restriction-induced pulmonary hypertension.
Wang Y; Dai S; Cheng X; Prado E; Yan L; Hu J; He Q; Lv Y; Lv Y; Du L
Nutr Metab Cardiovasc Dis; 2019 Jun; 29(6):639-651. PubMed ID: 30954415
[TBL] [Abstract][Full Text] [Related]
50. Monocrotaline-induced pulmonary arterial hypertension is attenuated by TNF-α antagonists via the suppression of TNF-α expression and NF-κB pathway in rats.
Wang Q; Zuo XR; Wang YY; Xie WP; Wang H; Zhang M
Vascul Pharmacol; 2013 Jan; 58(1-2):71-7. PubMed ID: 22846229
[TBL] [Abstract][Full Text] [Related]
51. Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model.
Liu CP; Dai ZK; Huang CH; Yeh JL; Wu BN; Wu JR; Chen IJ
Kaohsiung J Med Sci; 2014 Jun; 30(6):267-78. PubMed ID: 24835346
[TBL] [Abstract][Full Text] [Related]
52. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.
Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H
Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330
[TBL] [Abstract][Full Text] [Related]
53. The role of k+ channels in determining pulmonary vascular tone, oxygen sensing, cell proliferation, and apoptosis: implications in hypoxic pulmonary vasoconstriction and pulmonary arterial hypertension.
Moudgil R; Michelakis ED; Archer SL
Microcirculation; 2006 Dec; 13(8):615-32. PubMed ID: 17085423
[TBL] [Abstract][Full Text] [Related]
54. A urotensin II receptor antagonist, KR36676, decreases vascular remodeling and inflammation in experimental pulmonary hypertension.
Lee JH; Park BK; Oh KS; Yi KY; Lim CJ; Seo HW; Lee BH
Int Immunopharmacol; 2016 Nov; 40():196-202. PubMed ID: 27611861
[TBL] [Abstract][Full Text] [Related]
55. Function of Kv1.5 channels and genetic variations of KCNA5 in patients with idiopathic pulmonary arterial hypertension.
Remillard CV; Tigno DD; Platoshyn O; Burg ED; Brevnova EE; Conger D; Nicholson A; Rana BK; Channick RN; Rubin LJ; O'connor DT; Yuan JX
Am J Physiol Cell Physiol; 2007 May; 292(5):C1837-53. PubMed ID: 17267549
[TBL] [Abstract][Full Text] [Related]
56. Platelet-derived growth factor up-regulates Ca
Yamamura A; Nayeem MJ; Al Mamun A; Takahashi R; Hayashi H; Sato M
FASEB J; 2019 Jun; 33(6):7363-7374. PubMed ID: 30865840
[TBL] [Abstract][Full Text] [Related]
57. Function of NADPH oxidase 1 in pulmonary arterial smooth muscle cells after monocrotaline-induced pulmonary vascular remodeling.
Veit F; Pak O; Egemnazarov B; Roth M; Kosanovic D; Seimetz M; Sommer N; Ghofrani HA; Seeger W; Grimminger F; Brandes RP; Schermuly RT; Weissmann N
Antioxid Redox Signal; 2013 Dec; 19(18):2213-31. PubMed ID: 23706097
[TBL] [Abstract][Full Text] [Related]
58. Nestin represents a potential marker of pulmonary vascular remodeling in pulmonary arterial hypertension associated with congenital heart disease.
Zhou JJ; Li H; Qian YL; Quan RL; Chen XX; Li L; Li Y; Wang PH; Meng XM; Jing XL; He JG
J Mol Cell Cardiol; 2020 Dec; 149():41-53. PubMed ID: 32950539
[TBL] [Abstract][Full Text] [Related]
59. BMPRII influences the response of pulmonary microvascular endothelial cells to inflammatory mediators.
Vengethasamy L; Hautefort A; Tielemans B; Belge C; Perros F; Verleden S; Fadel E; Van Raemdonck D; Delcroix M; Quarck R
Pflugers Arch; 2016 Nov; 468(11-12):1969-1983. PubMed ID: 27816994
[TBL] [Abstract][Full Text] [Related]
60. Icotinib Attenuates Monocrotaline-Induced Pulmonary Hypertension by Preventing Pulmonary Arterial Smooth Muscle Cell Dysfunction.
Peng LY; Yu M; Yang MX; Liu P; Zhou H; Huang W; Kong H; Xie WP
Am J Hypertens; 2020 Aug; 33(8):775-783. PubMed ID: 32301965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
